Chester, John D <br/><br/>
Phase I and pharmacokinetic study of intravenous irinotecan plus oral ciclosporin in patients with fuorouracil-refractory metastatic colon cancer.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Mar 2003 
 - 1125-32 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2003.08.049  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Aged<br/>Antimetabolites, Antineoplastic--pharmacology<br/>Antineoplastic Agents, Phytogenic--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Camptothecin--administration & dosage<br/>Colonic Neoplasms--blood<br/>Cyclosporine--administration & dosage<br/>Drug Resistance, Neoplasm<br/>Female<br/>Fluorouracil--pharmacology<br/>Humans<br/>Infusions, Intravenous<br/>Irinotecan<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Treatment Outcome